Atox Bio announced new data in an animal model of necrotizing soft tissue infection (NSTI), commonly known as "flesh eating bacteria" demonstrating that administration of a single dose of AB103, given several hours after infection even without any antibiotics, increased survival in animals, and...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the New England Journal of Medicine (NEJM) published data from two Phase 3 studies of INCIVEK™ (telaprevir) tablets, which showed that INCIVEK (in-SEE-veck) combination therapy significantly improved rates of sustained viral...
NICE has today (21 October) published final draft guidance recommending the wider use of clopidogrel for the prevention of occlusive vascular events (ischaemic stroke , transient ischaemic attack [TIA] or heart attack) in people who have previously had an ischaemic stroke, or who have been...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company announced today that it has published results in the American Journal of Respiratory and Critical Care Medicine (Zamora et al., Am. J. Respir. Crit. Care Med., doi:10.1164/rccm.201003-0422OC, 2010) from its...
The role of pharmacy technicians is rapidly expanding, and demand for well-trained technicians continues to grow. The American Society of Health-System Pharmacists (ASHP) has released a new edition of its best-selling training resource, Manual for Pharmacy Technicians, 4th Edition, by Bonnie S...
The European Association for the Study of the Liver (EASL) - the leading European scientific society dedicated to promoting research and education in hepatology - publishes clinical practice guidelines for the management of ascites, the most common complication of cirrhosis. The peer reviewed...
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai"), together with its U.S. subsidiary Eisai Inc. and Arena Pharmaceuticals, Inc. announced today that the results from the two-year BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial...
Clinical and Laboratory Standards Institute (CLSI) recently published "Selection Criteria for Point-of-Care Testing Devices; Approved Guideline" (POCT09-A). This document provides guidance on selection of point-of-care testing (POCT) devices based on the patient care setting and clinical needs...
Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that a research paper describing the biological activity of its HDAC, EGFR and HER2 inhibitor, CUDC-101, was published online in...
do you think? Dr Roy Spencer, a leading climate scientist, has published his new book, "The Great Global Warming Blunder: How Mother Nature Fooled the World".
It argues that climate change is perfectly natural, and shows how and why some scientists have been misled into thinking that mankind is...
Yesterday, The Lancet published online the results of the first study comparing the once-daily human GLP-1 analog, Victoza® (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia®. The 26-week trial showed that Victoza® produced significantly greater reductions in A1C, fasting plasma...
magazine insisting that Congress? Mike, an advocate of a certain religion, publishes an article in New Times magazine insisting that Congress base all federal law on his religion's principles. The First Amendment guarantees Mike's freedom of
a.religion only.
b.the press, speech, and religion...
A new report examines and makes recommendations about the issue of self-monitoring of blood glucose (SMBG) in people with Type 2 diabetes who are not treated with insulin. The report was commissioned by the National Clinical Director for Diabetes in England. An NHS Diabetes working group was...
Millennium: The Takeda Oncology Company announced publication of an article in the journal Molecular Cell describing the mechanism of enzyme inhibition of MLN4924-a small molecule inhibitor of the NEDD8-Activating Enzyme (NAE), a key component of a protein homeostasis pathway. MLN4924 is the...
Millennium: The Takeda Oncology Company announced publication of an article in the journal Molecular Cell describing the mechanism of enzyme inhibition of MLN4924-a small molecule inhibitor of the NEDD8-Activating Enzyme (NAE), a key component of a protein homeostasis pathway. MLN4924 is the...
Millennium: The Takeda Oncology Company announced publication of an article in the journal Molecular Cell describing the mechanism of enzyme inhibition of MLN4924-a small molecule inhibitor of the NEDD8-Activating Enzyme (NAE), a key component of a protein homeostasis pathway. MLN4924 is the...
Full and finalised offshore health and safety statistics for 2008/09 are now available on the Health and Safety Executive (HSE) website. The detailed report follows the release of 'headline' statistics in August and contains figures on injury, ill-health and dangerous occurrences (see notes)...
Full and finalised offshore health and safety statistics for 2008/09 are now available on the Health and Safety Executive (HSE) website. The detailed report follows the release of 'headline' statistics in August and contains figures on injury, ill-health and dangerous occurrences (see notes)...
The Federal Trade Commission today announced that it has approved final revisions to the guidance it gives to advertisers on how to keep their endorsement and testimonial ads in line with the FTC Act.